Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics

European Journal of Clinical Pharmacology

Volumn 58, Issue 4, 2002, Pages

  Rosenborg, Johan ^a   Bengtsson, T ^a   Larsson, P ^a   Blomgren, A ^a   Persson, G ^a   Lotvall J ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Formoterol; Salbutamol; Tolerability

Indexed keywords

FORMOTEROL; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; ENANTIOSELECTIVITY; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METERED DOSE INHALER; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0036312047     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Inhaled beta2-adrenoceptor agonists in asthma: Help or hindrance
2. Formoterol fumarate, a new beta2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration
3. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency
4. Hypokalemia
5. The adrenal glands
6. Disorders of fluid volume, electrolytes, and acid-base balance
7. Risks versus benefits of inhaled beta2-agonists in the management of asthma
8. Subsensitivity of bronchodilator and systemic beta-2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients
9. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients
10. Guidelines on the management of asthma
11. American Thoracic Society: Chronic bronchitis, asthma and pulmonary emphysema
12. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma
13. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers
14. Some problems in biological assay
15. Insulin, glucagon, and diabetes mellitus
16. General principles of gastrointestinal function - Motility, nervous control, and blood circulation
17. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction
18. Normal values for QT intervals in ECG during ramp exercise on bicycle
19. Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol
20. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate
21. Enantiomeric disposition of inhaled intravenous and oral racemic salbutamol in man - No evidence of enantiomeric lung metabolism
22. Steric aspects of agonism and antagonism at β-adrenoceptors: Synthesis of and pharmacological experiments with the enantiomer of formoterol and their diastereomers